Chronic Lymphatic Leukemia Essay

Chronic lymphocytic leukemia (CLL) is a type of cancer of the bone marrow and blood cells. Bone marrow is the soft, spongy tissue inside your bone. In CLL, the bone marrow makes too many white blood cells. White blood cells usually fight infection in the body (lymphocytes). CLL usually gets worse slowly and is the most common type of adult leukemia.

A sample of blood is drawn to check for the number of red blood cells and platelets, the number and type of white blood cells, and the amount of hemoglobin in the red blood cells. Another form of testing is bone marrow aspiration and biopsy. This is the removal of bone marrow, blood and a small piece of bone by inserting a needle into the hipbone or breastbone. The pathologists will then exam the bone marrow to look for any abnormal cells. A Computed tomography (CT) exam might also be ordered. It is not one of the key ways of detecting chronic myelogenous leukemia but it assists in determining if some of the body’s vital organs are being affected. This test will tell if the spleen or the liver is

Bone marrow is the soft blood-forming tissue that fills the cavities of bones, it also has fat, immature and mature blood cells. Bone Marrow Aspiration and Bone Marrow Biopsy are different from each other in the sense that the aspiration is the liquid form of the tissue that is removed with the aspiration needle. The bone marrow biopsy is done with a biopsy needle and it removes the real marrow from the bone. (Islam, 2007)

Chronic Myeloid Leukemia is a cancer that affects your blood cells and bone marrow. Chronic myeloid leukemia (CML) is also called chronic myelogenous leukemia, it is the same disease, just different names. CML symptoms tend to come gradually and will usually happen to middle aged or older people. Furthermore, CML is caused when there is a problem in the genes of your blood cells. This causes two different chromosomes to switch places and make a new abnormal one. For this reason, CML has three phases; Chronic, accelerated, and blastic. Each phases has different symptoms and stages. In the event that a person is diagnosed with CML, there are treatments for each phase.

A review of his medical record indicates that his chronic myeloid leukemia (CML) is in remission. He is taking Tasigna 150mg (2 tabs) po daily as prescribed by his oncologist. He suffers from chronic pain syndrome due to his chronic back and neck pain. He also suffers from co-morbidities of GERD-stable, atherosclerotic heart disease -stable, COPD-chronic, hypertension-stable, and seizure disorder-stable.

Chronic myelocytic (or myelogenous) leukemia (CML) is a rare disease worldwide 2000); however, the innovative advances and successes of CML’s targeted-molecular therapy have kept CML “at the forefront of scientific attention” (Lee 2000). Like other forms of leukemia, CML is a type of cancer that starts in the blood-forming cells of the bone marrow. In particular, CML begins in myeloid stem cells, the cells that differentiate into platelets, red blood cells, and some white blood cells (e.g., granular leukocytes). These cells undergo genetic changes that cause white blood cells to not function normally and divide rapidly. The resulting abnormal leukemia cells build up in the bone marrow and interfere with the production of normal blood cells (platelets, RBCs, and granular leukocytes). Additionally, leukemia cells move into the blood stream and can spread to other organs (e.g., spleen). Unlike acute leukemia, which progresses very quickly, chronic leukemia progresses more slowly and can take a long time before causing health problems (American Cancer Society). According to the American Cancer Society, “one person in 55 will get CML in their lifetime in the United States” (American Cancer Society). The occurrence of the disease increases with age (average age of CML diagnosis: 64 years) and is rarely seen in children. For an unknown reason, slightly more males have CML as compared to females. The one potentially controllable risk factor is exposure to

To sample and process XLA the quantity of the B cells in the peripheral blood should be measured. An absence or a significantly low measurement of the B cells in the blood is the most distinguishing and trustworthy lab diagnosis in patients with XLA.

exposed to during treatment. Exposure to certain pesticides as a kid or even in the womb

Next, it depends on severity: Stage A- Average of 10 years life span. Stage B- 5-8 years. Stage C- 1-3 years. Finally CLL may go into remission, but it often comes back (Cancer Research UK).

Bone marrow biopsy: If results of the blood test are not normal, bone marrow may be examined. It is extracted through a thin needle inserted into the hip, after first numbing the area with an injection. The marrow will be examined under the microscope to examine abnormal cells.

• A complete blood count (CBC). This test measures all the types of blood cells in your body.

Leukemia which is also known as blood cancer is a malignant progressive disease in which the bone marrow and other blood-forming organs produce increased numbers of abnormal leukocytes. There is no known reason of what actually causes the cancer leukemia but they do believe that it involves a combination of genetic and environmental factors. Some of the common symptoms of leukemia is feeling weak, weight loss, bruising easily and many of other things. There are different types of leukemia the most common types are Acute lymphocytic leukemia(ALL) , Acute myeloid leukemia (AML) , Chronic lymphocytic leukemia (CLL) , and Chronic myeloid leukemia (CML).

Now, in order to examine if a patient has CLL, he must have at least 5,000/mm3 of monoclonal lymphocytes (sometimes called a monoclonal lymphocytosis), but the overall lymphocyte count does not have to be high.

Causes for common non-Hodgkin lymphomas may be autoimmune diseases, HIV/AIDS, infection with human T-lymphotropic virus, eating excessive amounts of meat and fat, immunosuppressant medications, and some pesticides. Lymphoma most often spreads to the lungs, liver, and/or

has been shown to be a factor in the incidences of leukemia and sometimes it is